期刊文献+

2型糖尿病患者血栓调节蛋白水平与冠心病的关系

The relathinship of conronary arterial lesion and the plasma thrombomodulin in type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨2型糖尿病患者血栓调节蛋白(thrombomodulin,TM)水平与合并冠心病的关系。方法选择2007年1月至2008年3月在本院住院的97例糖尿病患者,把合并冠心病患者分为稳定性心绞痛组、不稳定性心绞痛组和心肌梗死组。应用酶联免疫吸附测定(ELISA)检测其血浆TM水平,并对血浆TM与冠状动脉病变作相关分析。结果不稳定性心绞痛组血浆TM水平高于稳定性心绞痛组;心肌梗死组明显高于不稳定性心绞痛组。结论2型糖尿病合并冠心病患者,随着冠状动脉粥样硬化病变程度加重,血浆TM水平可能相应升高。监测2型糖尿病患者血浆TM水平,对预测其冠状动脉粥样硬化病的严重程度可能有一定意义。 Objective To evaluate the relationship between the plasma thrombomodulin level and severity of coronary arterial lesion in patients with type 2 diabetes mellitus (T2DM) complicated with conronary heart disease. Methods The venous blood samples were obtained from 97 patients with type 2 diabetes mellitus (T2DM) after they were in hosptial. Patients with type 2 diabetes mellitus (T2DM)complicated with coronary heart disease were divided into stable angina pectoris grops, instable angina pectoris grops and myocardial infarction group. The the plasma thrombomodulin levels were determined by enzyme-linked immunosorbent assay (ELISA). The relationship between the plasma thrombomodulin level and severity of coronary arterial lesion was observed. Results The plasma thrombomodulin concentrations of instable angina pectoris group were significantly higher than those of stable angina pectoris group, their levels of myocardial infarction group were higher than those of instable angina pectoris group. Conclusions Higher level of the plasma thrombomodulin is associated with increased severity of coronary arterial lesion in T2DM. It suggests that serum concentrations of the plasma thrombomodulin can be a parameter for predicting the severity of coronary arterial lesion in T2DM.
作者 张国平
机构地区 江西省人民医院
出处 《中国实用医药》 2009年第11期21-22,共2页 China Practical Medicine
关键词 冠心病 2型糖尿病 血栓调节蛋白 Coronary heart disease Type 2 diabetes mellitus The plasma thrombomodulin
  • 相关文献

参考文献8

二级参考文献39

  • 1王月玲,杨娜,杨玉珍,张峻霄.血栓调节蛋白在子宫内膜癌组织中的表达[J].西安交通大学学报(医学版),2004,25(5):475-477. 被引量:2
  • 2曾正陪,唐丹,孙梅励,关炳江,吕朝,王.血浆内皮素与糖尿病血管病变的关系[J].中华内科杂志,1994,33(7):467-469. 被引量:78
  • 3Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies : Part I. Circulation, 2003,108 : 1664-1672.
  • 4Shebuski R J, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther, 2002,300 : 729-735.
  • 5Carter AM, Anagnostopoulou K, Mansfield MW, et al. Soluble P-selectin levels, P-selectin polyrnorphisms and cardiovascular disease. J Thromb Haemost,2003,1 : 1718-1723.
  • 6Braunwald E, Antman EM, Beasley JW, et ah ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2000, 36:970-1062.
  • 7Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983,51 : 606.
  • 8Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( committee to revise the 1993 guidelines for percutaneous translurninal coronary angioplasty ). J Am Coll Cardiol,2001,37 : 2215-2239.
  • 9Johnson RC, Chapman SM, Dong ZM, et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest, 1997, 99 :1037-1040.
  • 10Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advance atherosclerosis in apoE-deficient mice.Circulation, 2000,101:2290-2295.

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部